Close Menu

NEW YORK – In June, the Association for Molecular Pathology (AMP) and the College of American Pathologists (AMP) sent a letter to US Centers for Medicare and Medicaid Services contractor Palmetto GBA regarding its proposed coverage policy for next-generation sequencing lab-developed tests for myeloid malignancies and suspected myeloid malignancies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.